[Health] - U.S. FDA to review Teva and Celltrion's cancer biosimilar drug | REUTERS
reuters.com/article/us-teva-pharm-ind-celltri...
reuters.comPosted Jul 31, 2017, 2:42 PM UTC
10
reuters.comLoading comments…
reuters.comreuters.comPosted Jul 31, 2017, 2:42 PM UTC